Itron (NASDAQ:ITRI) Sets New 12-Month Low – Here’s What Happened

Itron, Inc. (NASDAQ:ITRIGet Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $78.03 and last traded at $77.99, with a volume of 455727 shares trading hands. The stock had previously closed at $80.80.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

  • Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and set a $130 price target, implying meaningful upside from recent levels. Stephens reaffirms Overweight on Itron
  • Neutral Sentiment: Several executives sold relatively small amounts of stock, but the company said the transactions were tied to tax withholding obligations related to vesting equity awards, which makes them less concerning than open-market selling. Among the sellers were CFO Joan S. Hooper and SVPs John F. Marcolini, Justin K. Patrick, Laurie Ann Pulatie-Hahn, Donald L. Reeves III, Christopher E. Ware, and CAO David Marshall Wright.
  • Negative Sentiment: Zacks Research trimmed its earnings estimates for Itron, cutting Q2 2026 EPS to $1.31 from $1.44, Q3 2026 EPS to $1.52 from $1.55, and Q1 2028 EPS to $1.77 from $1.99, while keeping a Hold rating. Zacks cuts Itron estimates
  • Negative Sentiment: The same research note also nudged down FY2026 EPS to $5.97 from $5.98, signaling slightly softer near-term expectations for the business.

Analysts Set New Price Targets

A number of analysts recently issued reports on ITRI shares. Raymond James Financial started coverage on Itron in a research report on Tuesday, April 21st. They set an “underperform” rating for the company. Guggenheim set a $155.00 price objective on Itron in a research report on Friday, February 13th. Stephens reissued an “overweight” rating and set a $130.00 price objective on shares of Itron in a research report on Wednesday. Oppenheimer lifted their price objective on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research report on Thursday, April 16th. Finally, Robert W. Baird set a $128.00 price objective on Itron and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $131.22.

Read Our Latest Report on ITRI

Itron Stock Up 0.6%

The business has a 50-day simple moving average of $88.63 and a two-hundred day simple moving average of $94.60. The company has a market cap of $3.63 billion, a price-to-earnings ratio of 13.05, a PEG ratio of 0.71 and a beta of 1.35. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97.

Itron (NASDAQ:ITRIGet Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. Itron had a return on equity of 19.54% and a net margin of 12.31%.The company had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same quarter in the previous year, the firm earned $1.52 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities analysts forecast that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Itron news, CFO Joan S. Hooper sold 355 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total value of $28,258.00. Following the completion of the sale, the chief financial officer owned 117,920 shares of the company’s stock, valued at $9,386,432. The trade was a 0.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Justin K. Patrick sold 828 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $82,940.76. Following the completion of the sale, the senior vice president directly owned 33,516 shares of the company’s stock, valued at $3,357,297.72. This represents a 2.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 11,863 shares of company stock valued at $1,138,275. 1.77% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Itron

Institutional investors have recently made changes to their positions in the business. DLD Asset Management LP increased its stake in Itron by 49.9% during the third quarter. DLD Asset Management LP now owns 63,400 shares of the scientific and technical instruments company’s stock valued at $7,897,000 after acquiring an additional 21,100 shares during the period. Thrivent Financial for Lutherans increased its stake in Itron by 78.3% during the third quarter. Thrivent Financial for Lutherans now owns 77,488 shares of the scientific and technical instruments company’s stock valued at $9,653,000 after acquiring an additional 34,027 shares during the period. J. Safra Sarasin Holding AG bought a new position in Itron during the third quarter valued at about $4,673,000. Elo Mutual Pension Insurance Co bought a new position in Itron during the third quarter valued at about $1,672,000. Finally, Envestnet Asset Management Inc. grew its stake in shares of Itron by 34.0% in the 3rd quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock valued at $18,474,000 after purchasing an additional 37,634 shares during the period. 96.19% of the stock is currently owned by institutional investors.

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Articles

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.